Q1 2019 13F Holders as of 3/31/2019
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
55.2M
-
Number of holders
-
106
-
Total 13F shares, excl. options
-
27.2M
-
Shares change
-
-622K
-
Total reported value, excl. options
-
$520M
-
Value change
-
+$3.58M
-
Put/Call ratio
-
0.2
-
Number of buys
-
55
-
Number of sells
-
-52
-
Price
-
$19.14
Significant Holders of Voyager Therapeutics, Inc. - Common Stock, $0.001 par value (VYGR) as of Q1 2019
133 filings reported holding VYGR - Voyager Therapeutics, Inc. - Common Stock, $0.001 par value as of Q1 2019.
Voyager Therapeutics, Inc. - Common Stock, $0.001 par value (VYGR) has 106 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 27.2M shares
of 55.2M outstanding shares and own 49.21% of the company stock.
Largest 10 shareholders include TRV GP III, LLC (6.39M shares), BB BIOTECH AG (2.87M shares), Partner Fund Management, L.P. (1.95M shares), BlackRock Inc. (1.89M shares), ARMISTICE CAPITAL, LLC (1.54M shares), VANGUARD GROUP INC (1.39M shares), Casdin Capital, LLC (1.13M shares), FARALLON CAPITAL MANAGEMENT LLC (1M shares), FMR LLC (738K shares), and HIGHLINE CAPITAL MANAGEMENT, L.P. (589K shares).
This table shows the top 106 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.